Important Warnings and Instructions for Heparin Sodium Injection (Baxter)

Citation: U.S. Food and Drug Administration (2008).
28 Feburary 2008.

The Food and Drug Administration is issuing this alert to:

- inform the public about reports of serious adverse events in patients who received bolus injections of heparin sodium for injection primarily from multiple-dose vials manufactured by Baxter Healthcare Corporation, and to

- recommend measures that may help to minimize these risks if this product must be used due to medical necessity.

The full article can be viewed at:
http://www.fda.gov/cder/drug/advisory/heparin.htm